Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract

Infection and Immunity

Volumn 83, Issue 3, 2015, Pages 934-941

  Koenigsknecht, Mark J ^a   Theriot, Casey M ^a   Bergin, Ingrid L ^a   Schumacher, Cassie A ^a   Schloss, Patrick D ^a   Young, Vincent B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CEFOPERAZONE; CYTOTOXIN; TOXIN; ANTIINFECTIVE AGENT; ENTEROTOXIN; ENTEROTOXIN, CLOSTRIDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL SPORE; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; EX VIVO STUDY; FEMALE; GASTROINTESTINAL INFECTION; HISTOPATHOLOGY; INFECTION SENSITIVITY; INTESTINE FLORA; LARGE INTESTINE; MALE; MICROBIAL COMMUNITY; MICROFLORA; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; SMALL INTESTINE; SPORE GERMINATION; SPOROGENESIS; VEGETATIVE GROWTH; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHEMISTRY; CLOSTRIDIUM INFECTIONS; DRUG EFFECTS; FECES; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; MORTALITY; PATHOGENICITY; PATHOLOGY; SECRETION (PROCESS); SURVIVAL ANALYSIS; TIME FACTOR;

ANIMALS; ANTI-BACTERIAL AGENTS; BILE ACIDS AND SALTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS; DISEASE PROGRESSION; ENTEROTOXINS; FECES; FEMALE; GASTROINTESTINAL TRACT; MALE; MICE; MICE, INBRED C57BL; MICROBIOTA; SPORES, BACTERIAL; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84922971911     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02768-14     Document Type: Article

References (34)

1. Dubberke ER, Olsen MA. 2012. Burden of Clostridium difficile on the health care system. Clin Infect Dis 55(Suppl 2):S88-S92. http://dx.doi.org/10.1093/cid/cis335.
2. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7:526-536. http://dx.doi.org/10.1038/nrmicro2164.
3. Paredes-Sabja D, Shen A, Sorg JA. 2014. Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol 22:406-416. http://dx.doi.org/10.1016/j.tim.2014.04.003.
4. Britton RA, Young VB. 2012. Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol 20:313-319. http://dx.doi.org/10.1016/j.tim.2012.04.001.
5. Buffie CG, Pamer EG. 2013. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13:790-801. http://dx.doi.org/10.1038/nri3535.
6. Yurist-Doutsch S, Arrieta MC, Vogt SL, Finlay BB. 2014. Gastrointestinal microbiota-mediated control of enteric pathogens. Annu Rev Genet 48:361-382. http://dx.doi.org/10.1146/annurev-genet-120213-092421.
7. Theriot CM, Koenigsknecht MJ, Carlson PE, Jr, Hatton GE, Nelson AM, Li B, Huffnagle GB, Li JZ, Young VB. 2014. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 5:3114. http://dx.doi.org/10.1038/ncomms4114.
8. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M, Backhed F. 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-betamuricholic acid, a naturally occurring FXR antagonist. Cell Metab 17: 225-235. http://dx.doi.org/10.1016/j.cmet.2013.01.003.
9. Ridlon JM, Kang DJ, Hylemon PB. 2006. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47:241-259.
10. Sorg JA, Sonenshein AL. 2009. Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J Bacteriol 191:1115-1117. http://dx.doi.org/10.1128/JB.01260-08.
11. Reeves AE, Koenigsknecht MJ, Bergin IL, Young VB. 2012. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun 80:3786-3794. http://dx.doi.org/10.1128/IAI.00647-12.
12. Best EL, Freeman J, Wilcox MH. 2012. Models for the study of Clostridium difficile infection. Gut Microbes 3:145-167. http://dx.doi.org/10.4161/gmic.19526.
13. Lawley TD, Young VB. 2013. Murine models to study Clostridium difficile infection and transmission. Anaerobe 24:94-97. http://dx.doi.org/10.1016/j.anaerobe.2013.09.008.
14. Perez J, Springthorpe VS, Sattar SA. 2011. Clospore: a liquid medium for producing high titers of semipurified spores of Clostridium difficile. J AOAC Int 94:618-626.
15. Theriot CM, Koumpouras CC, Carlson PE, Bergin II, Aronoff DM, Young VB. 2011. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes 2:326-334. http://dx.doi.org/10.4161/gmic.19142.
16. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. 2013. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol 79:5112-5120. http://dx.doi.org/10.1128/AEM.01043-13.
17. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75:7537-7541. http://dx.doi.org/10.1128/AEM.01541-09.
18. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, Glockner FO. 2007. SILVA: a comprehensive online resource for quality checked and aligned rRNA sequence data compatible with ARB. Nucleic Acids Res 35:7188-7196. http://dx.doi.org/10.1093/nar/gkm864.
19. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. 2011. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27: 2194-2200. http://dx.doi.org/10.1093/bioinformatics/btr381.
20. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM, Tiedje JM. 2009. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 37:D141-D145. http://dx.doi.org/10.1093/nar/gkn879.
21. Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, Viale A, Ubeda C, Xavier J, Pamer EG. 2012. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 80:62-73. http://dx.doi.org/10.1128/IAI.05496-11.
22. Sorg JA, Sonenshein AL. 2008. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 190:2505-2512. http://dx.doi.org/10.1128/JB.01765-07.
23. Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. 2011. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile infection. Gut Microbes 2:145-158. http://dx.doi.org/10.4161/gmic.2.3.16333.
24. Barketi-Klai A, Monot M, Hoys S, Lambert-Bordes S, Kuehne SA, Minton N, Collignon A, Dupuy B, Kansau I. 2014. The flagellin FliC of Clostridium difficile is responsible for pleiotropic gene regulation during in vivo infection. PLoS One 9:e96876. http://dx.doi.org/10.1371/journal.pone.0096876.
25. Underwood S, Guan S, Vijayasubhash V, Baines SD, Graham L, Lewis RJ, Wilcox MH, Stephenson K. 2009. Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J Bacteriol 191:7296-7305. http://dx.doi.org/10.1128/JB.00882-09.
26. Mackin KE, Carter GP, Howarth P, Rood JI, Lyras D. 2013. Spo0A differentially regulates toxin production in evolutionarily diverse strains of Clostridium difficile. PLoS One 8:e79666. http://dx.doi.org/10.1371/journal.pone.0079666.
27. Bouillaut L, Dubois T, Sonenshein AL, Dupuy B. Integration of metabolism and virulence in Clostridium difficile. Res Microbiol, in press.
28. Giel JL, Sorg JA, Sonenshein AL, Zhu J. 2010. Metabolism of bile salts in mice influences spore germination in Clostridium difficile. PLoS One 5:e8740. http://dx.doi.org/10.1371/journal.pone.0008740.
29. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. 1977. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 136:701-705. http://dx.doi.org/10.1093/infdis/136.5.701.
30. Wilson KH, Sheagren JN, Freter R. 1985. Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis 151:355-361. http://dx.doi.org/10.1093/infdis/151.2.355.
31. Howerton A, Ramirez N, Abel-Santos E. 2011. Mapping interactions between germinants and Clostridium difficile spores. J Bacteriol 193:274-282. http://dx.doi.org/10.1128/JB.00980-10.
32. Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, Littmann E, van den Brink MR, Jenq RR, Taur Y, Sander C, Cross J, Toussaint NC, Xavier JB, Pamer EG. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature, in press.
33. Sorg JA. 2014. Microbial bile acid metabolic clusters: the bouncers at the bar. Cell Host Microbe 16:551-552. http://dx.doi.org/10.1016/j.chom.2014.10.015.
34. Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM, Sonnenburg JL. 2013. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502:96-99. http://dx.doi.org/10.1038/nature12503.